U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316062) titled 'A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China' on Dec. 05, 2025.
Brief Summary: This chart review study is proposed in China to understand the treatment patterns, biomarker testing, and clinical outcomes with SOC and some selected regimens among patients diagnosed with stage I-III NSCLC.
Study Start Date: April 15, 2026
Study Type: OBSERVATIONAL
Condition:
Non-Small-Cell Lung
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....